A Quantitative and Qualitative Analysis of the Patient and Caregiver’s Perspective on Outcomes of Intravenous Administration of Low-Dose Ketamine for C-PTSD, TBI, and Treatment Resistant MDD: A Clinical Example
<b>Background and Clinical Significance</b>: Treatment resistant psychiatric disorders affect millions of people across the globe. Ketamine has been employed as a treatment option for those with treatment resistant depression, as well as for chronic pain and alcohol use disorder. However...
Saved in:
| Main Authors: | Laura Hentig, James Hentig, Jessica M. Gill |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Reports |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2571-841X/8/1/13 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Appetite measures as correlates of clinical response in mood disorders treated with ketamine: systematic review
by: Jakub Słupski, et al.
Published: (2025-08-01) -
Response to Training in Emotion Recognition Function for Mild TBI/PTSD Survivors: Pilot Study
by: J. Kay Waid-Ebbs, et al.
Published: (2025-07-01) -
Inside the journey: A qualitative study of intravenous ketamine therapy for treatment-resistant depression
by: Jason Perepelkin, et al.
Published: (2025-04-01) -
Comprehensive Characterization of Antidepressant Pharmacogenetics: A Systematic Review of Studies in Major Depressive Disorder
by: Caroline W. Grant, et al.
Published: (2025-06-01) -
Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant depression: a naturalistic feasibility study
by: Katelyn Halpape, et al.
Published: (2025-01-01)